Tunisia
· Delayed Price · Currency is TND UMED Statistics
Total Valuation
Unité de Fabrication des Médicaments S.A has a market cap or net worth of TND 226.88 million. The enterprise value is 272.43 million.
| Market Cap | 226.88M |
| Enterprise Value | 272.43M |
Important Dates
The next estimated earnings date is Friday, September 13, 2024.
| Earnings Date | Sep 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Unité de Fabrication des Médicaments S.A has 32.00 million shares outstanding.
| Shares Outstanding | 32.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 40.91 and the forward PE ratio is 9.09.
| PE Ratio | 40.91 |
| Forward PE | 9.09 |
| PS Ratio | 1.67 |
| PB Ratio | 2.41 |
| P/FCF Ratio | 12.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.97, with an EV/FCF ratio of 14.59.
| EV / Earnings | 49.12 |
| EV / Sales | 2.00 |
| EV / EBITDA | 6.97 |
| EV / EBIT | 9.36 |
| EV / FCF | 14.59 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 54.68.
| Current Ratio | 1.42 |
| Quick Ratio | 0.68 |
| Debt / Equity | 54.68 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 2.76 |
| Interest Coverage | 4.68 |
Financial Efficiency
Return on equity (ROE) is 5.60% and return on invested capital (ROIC) is 11.94%.
| Return on Equity (ROE) | 5.60% |
| Return on Assets (ROA) | 9.52% |
| Return on Capital (ROIC) | 11.94% |
| Revenue Per Employee | 237,767 |
| Profits Per Employee | 9,696 |
| Employee Count | 572 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.48% |
| 50-Day Moving Average | 7.04 |
| 200-Day Moving Average | 7.09 |
| Relative Strength Index (RSI) | 49.69 |
| Average Volume (20 Days) | 11,099 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Unité de Fabrication des Médicaments S.A had revenue of TND 136.00 million and earned 5.55 million in profits. Earnings per share was 0.17.
| Revenue | 136.00M |
| Gross Profit | 74.29M |
| Operating Income | 29.11M |
| Pretax Income | 10.99M |
| Net Income | 5.55M |
| EBITDA | 39.11M |
| EBIT | 29.11M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 5.98 million in cash and 51.53 million in debt, giving a net cash position of -45.55 million or -1.42 per share.
| Cash & Cash Equivalents | 5.98M |
| Total Debt | 51.53M |
| Net Cash | -45.55M |
| Net Cash Per Share | -1.42 |
| Equity (Book Value) | 94.25M |
| Book Value Per Share | 2.95 |
| Working Capital | 33.68M |
Cash Flow
In the last 12 months, operating cash flow was 31.77 million and capital expenditures -13.09 million, giving a free cash flow of 18.68 million.
| Operating Cash Flow | 31.77M |
| Capital Expenditures | -13.09M |
| Free Cash Flow | 18.68M |
| FCF Per Share | 0.58 |
Margins
Gross margin is 54.62%, with operating and profit margins of 21.40% and 4.08%.
| Gross Margin | 54.62% |
| Operating Margin | 21.40% |
| Pretax Margin | 8.08% |
| Profit Margin | 4.08% |
| EBITDA Margin | 28.75% |
| EBIT Margin | 21.40% |
| FCF Margin | 13.73% |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 6.61%.
| Dividend Per Share | 0.47 |
| Dividend Yield | 6.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 270.58% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.61% |
| Earnings Yield | 2.44% |
| FCF Yield | 8.23% |
Stock Splits
The last stock split was on August 4, 2017. It was a forward split with a ratio of 1.0940200862.
| Last Split Date | Aug 4, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0940200862 |